IMI

@IMI_JU

The Innovative Medicines Initiative (IMI) is a public-private partnership aiming to speed up development of medicines. Data protection:

Brussels
Vrijeme pridruživanja: lipanj 2010.

Tweetovi

Blokirali ste korisnika/cu @IMI_JU

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IMI_JU

  1. Prikvačeni tweet
    21. sij

    IMI news: Cancer, tuberculosis and vaccines in new IMI Call for proposals Press release: All Call documents: Sign up for the webinars:

    Poništi
  2. proslijedio/la je Tweet
    prije 12 sati

    Kick-off meeting of EUPATI Reload : project that will transform and redesign the course. Stay tuned for more information!👉

    Poništi
  3. proslijedio/la je Tweet
    prije 16 sati

    Spotlight on early-career researchers interview! 🧪🌟 Lianne Reus from the project shows how projects involving industry & academia increase our understanding of the biological substrate underlying social withdrawal. 👉👉👉

    , , i još njih 3
    Poništi
  4. proslijedio/la je Tweet

    Successful first day at the IDEA-FAST kick-off meeting. Big thank you for organising this event and making this possible!

    Poništi
  5. prije 13 sati

    This month we're talking about IMI's research. Since 2010 we've been breaking down the research roadblocks that are holding up new and better cancer treatments. Read the editorial by IMI Director Pierre Meulien ➡️

    Poništi
  6. proslijedio/la je Tweet
    4. velj

    Dr. C. Mathieu receives the David Rumbough Award, recognizing outstanding achievements in the field of T1D, significantly accelerating the mission. Congratulations! 2 more INNODIA partners were awarded today. Coming up.

    Poništi
  7. proslijedio/la je Tweet
    prije 20 sati

    Congratulations to Dr. Teresa Rodriguez-Calvo, partner from Helmholtz Zentrum, who won the Dr. Robert Goldstein Award at . The focus of her work is on understanding if beta cells are dysfunctional before onset.

    Poništi
  8. proslijedio/la je Tweet
    prije 19 sati

    Influenza effectiveness against laboratory-confirmed in Europe: results from DRIVE network 2018/19 funded by . Read more on website

    Poništi
  9. 4. velj

    Meet the newly elected leaders of the IMI States Representatives Group! Chair: Marta Gómez Quintanilla 🇪🇸 Vice-Chair: Jan Skriwanek 🇩🇪 Thanks to outgoing chair Gunnar Sandberg 🇸🇪 for his work for the group Meet the SRG

    Jan Skriwanek and Marta Gómez Quintanilla
    Poništi
  10. 4. velj

    Like cancer, scientific breakthroughs can be decades in the making. It’s early days, but with 11 funded projects so far, IMI research will no doubt play a role in achieving the

    Poništi
  11. 4. velj

    Did you know...? The cost of NOT having FAIR (findable, accessible, interoperable, reusable) data could be EUR 10 bn a year! This + other interesting facts in a presentation by our project at our SRG meeting in Brussels today.

    Poništi
  12. proslijedio/la je Tweet
    4. velj

    DRIVE Press release Call for Research Collaborators to Join New Efforts to Study Brand-specific Influenza - DRIVE Help us increasing awareness and understanding of effectiveness. Join DRIVE Project , funded by

    , , i još njih 7
    Poništi
  13. proslijedio/la je Tweet
    4. velj

    Currently, the 6th Steering Committee Meeting in Frankfurt is taking place. is in the final phase. Over the next two months all partners will work full steam to reach the goals and present all findings.

    Poništi
  14. proslijedio/la je Tweet
    4. velj

    COMBACTE-NET's newest (platform) trial HONEST-PREPS received its first ethical committee approval in record time, in Serbia. The aim of the study is to set up an infrastructure to prospectively enroll patients at risks of HAP/VAP in the ICU

    Poništi
  15. 4. velj

    Lack of quality data on blood cancers is a problem. Big data project is pooling data from across EU to better understand the different cancer subtypes, ultimately leading to better treatments.

    Poništi
  16. 4. velj

    It's . How are we contributing to the ? The last 3 IMI calls for proposals have pitched another €26 million to the €130 million already dedicated to cancer research projects. today launches public outreach

    Poništi
  17. 4. velj

    Today's SRG agenda includes: ✅IMI's portfolio including ✅the benefits of being an IMI Associated Partner with ✅IMI's scientific priorities for 2020 ✅the election of a new chair and vice-chair

    Prikaži ovu nit
    Poništi
  18. 4. velj

    IMI director Pierre Meulien meets 3 new members of our States Representatives Group at their meeting in Brussels today: Myriam Cevallos🇨🇭 Helena Viita 🇫🇮 & Martha Cahill 🇮🇪 ➡️Meet the rest of the SRG at

    Left to right: Myriam Cevallos, Helena Viita, Martha Cahill and Pierre Meulien
    Prikaži ovu nit
    Poništi
  19. proslijedio/la je Tweet
    4. velj

    Collaborative initiatives on the - is proud to be associated with the () & () to address 3Rs through implementing new research paradigms and developing more predictive testing tools

    Poništi
  20. proslijedio/la je Tweet
    4. velj

    Today in Brussels I attend the States Representative Group of , as a french representative. Nice to discuss about improving partnerships on european innovation in health

    Poništi
  21. proslijedio/la je Tweet

    We are working on all fronts to fight : - Supported repatriation of 447 EU citizens from Wuhan - Helping Chinese authorities provide protective equipment - Providing supplies - coordinating EU assistance - €10M for vaccine research

    Samples in the lab
    , , i još njih 2
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·